BackCVS Bay Area Overview

CVS Bay Area EBIT

Latest ebit for 2687.T: $180M, below the sector sector average of $2.6T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$12.95M
↑ 41.52% YoY

As of Aug 31, 2026

Annual EBIT (TTM)

$175.15M
↑ 7.77% YoY

Trailing 12 months ending Aug 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

CVS Bay Area (2687.T) FAQ

As of the most recent data (August 2026), 2687.T shows a EBIT of $180M. That compares with $160M in the prior-year period — up 7.8% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 2687.T's EBIT is now $180M (was $160M) — a 7.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CVS Bay Area is outperforming or lagging.

The its sector sector average EBIT is about $2.6T. CVS Bay Area is at $180M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how 2687.T stacks up against individual peers as well.

Tracking 2687.T's ebit over time shows whether CVS Bay Area is scaling, shrinking, or reshaping that part of the business. The current reading is $180M That compares with $160M in the prior-year period — up 7.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has CVS Bay Area's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $180M) with ownership activity and broader fundamentals.